Page 1893 - Williams Hematology ( PDFDrive )
P. 1893

1868           Part XII:  Hemostasis and Thrombosis                                                                                                      Chapter 112:  Platelet Morphology, Biochemistry, and Function           1869




                   Shear stress is an important factor in GPIb-mediated adhe-  effects. 1143,1144  GPIb has also been implicated in supporting metastases
               sion of platelets to immobilized VWF and subendothelial sur-  in murine models. 1145
               faces. 1042,1113,1120–1122,1124,1125  Platelets deficient in GPIb or platelets in which   GPV, the third  member  of the  GPIb/IX/V complex, has  a Mr
               GPIb has been blocked with monoclonal antibodies 1122,1124  adhere poorly   82,000 and is composed of 544 amino acids, including 15 leucine-rich
               to subendothelial surfaces at all shear rates, but the defect in blood from   repeats. GPV appears to form a noncovalent complex with GPIb,
               patients with von Willebrand disease is manifest primarily at higher   mediated through association of their transmembrane domains, 1146
               shear rates. 10,11,1122  In what may be a related phenomenon, subjecting   but because the number of GPV molecules on the surface of platelets
               platelets to high shear stresses can induce platelet aggregation, which is   is approximately 50 percent of the number of GPIb and GPIX mole-
               mediated by VWF binding to GPIb, followed by platelet activation and   cules, 1147  it has been suggested that the basic unit consists of two GPIb
               integrin α β -dependent platelet aggregation. 13,15,1126  Whether the shear   molecules, two GPIX molecules, and one GPV molecule. 801,1035,1038
                      IIb 3
               rates generated in vivo in stenotic blood vessels are of sufficient magni-  GPV is deficient in platelets from patients with Bernard-Soulier syn-
               tude and duration to produce a similar degree of platelet activation is   drome (Chap. 121), but GPV is not required for surface expression of
               unknown. It is also uncertain as to whether the effect of shear is acting   the GPIb/IX complex. 1148  A soluble fragment of Mr 69,000 is cleaved
               on GPIb, on VWF, or on both, 15,801,809,1042  but shear-induced changes in   from GPV by thrombin, but cleavage does not correlate with thrombin-
               the structure of VWF, leading to a more extended conformation and   induced platelet activation. 1149  Platelets from mice lacking GPV appear
               conformational changes in the A1 domain, have been defined. 1113,1127    to respond more actively to thrombin and ADP than wild-type mice,
               GPIb forms catch bonds with VWF, meaning that increasing force first   raising the possibility that GPV inhibits platelet activation. 1150  The plate-
               prolongs and then shortens bond lifetimes. 1113,1128   lets from these mice also adhere to immobilized VWF and can bind
                   GPIb also functions as a platelet binding site for thrombin. 801,1129,1130    VWF in the presence of botrocetin, indicating that GPV is not required
               The regions between amino acids 216 and 240 and amino acids 269   for the interaction between VWF and the GPIb/IX/V complex. 1150  It has
               and 287 were proposed as thrombin binding sites based on biochem-  been proposed that removing a portion of GPV by thrombin proteolysis
               ical data, with the latter region demonstrating similarity to hirudin, a   allows thrombin access to GPIbα, thus facilitating its ability to activate
               thrombin-binding protein. 801,1131  Sulfation of the three tyrosine residues   platelets. In support of this model, thrombin’s ability to activate platelets
               in the latter region is particularly important for thrombin binding. 1093  does not require proteolytic activity if GPV is absent, suggesting a direct
                   Two somewhat different crystal structures of the interactions   nonproteolytic effect mediated via GPIbα. 1151
               between thrombin and the negatively charged tail region of GPIb have
               been reported, but in both cases two molecules of thrombin bind to   IMMUNOGLOBULIN FAMILY OF
               each GPIb molecule using different regions on thrombin (exosites I and   CELL-SURFACE ADHESION RECEPTORS AND
               II). This raises the possibility that free thrombin or thrombin adherent   THEIR ASSOCIATED MEMBRANE PROTEINS
               to fibrin can cluster GPIb/IX/V complexes. 1132
                   Binding of thrombin to platelet GPIb appears to contribute to   Platelet-Endothelial Cell Adhesion Molecule-1 (Also Termed
               thrombin-induced activation of platelets, even when PAR-1 and PAR-4   CD31)
               are desensitized, and platelets lacking GPIb (Bernard-Soulier syn-  PECAM-1 is a transmembrane glycoprotein of the immunoglobulin
               drome) do, in fact, have blunted responses to thrombin. GPIb has been   gene family with six immunoglobulin-like domains of the C2 group
               proposed as the high-affinity binding site for thrombin, 1129,1133  but there   and a Mr 130,000. 1152–1155  In addition to platelets and endothelial cells,
               are only approximately 50 high-affinity thrombin-binding sites and   PECAM-1 is expressed on monocytes, myeloid cells, and some lym-
               approximately 25,000 GPIb molecules per platelet, 1129,1130  raising the   phocyte subsets. There are approximately 8000 PECAM-1 molecules on
               possibility that only the subpopulation of GPIb molecules in lipid rafts   the surface of platelets. 1156  PECAM promotes homophilic interactions
               are able to function in activating platelets. 1134  Binding of thrombin to   via a homophilic binding domain in the immunoglobin-like repeats.
               GPIb may also facilitate its effect on one or more of the other thrombin   The cytoplasmic tail of PECAM is 118 amino acids in length and con-
               receptors, and there is experimental support for this hypothesis. 1135,1136  tains a palmitoylation site (C595), an immunoreceptor tyrosine-based
                   GPIb has also been demonstrated to interact with P-selectin in a   inhibitory motif (ITIM) including Y663, an immunoreceptor tyrosine-
               cation-independent manner. 764,1035,1093  Although GPIb shares a number   based switch motif (ITSM) including Y686, and a lipid-interacting α
               of features with the P-selectin ligand, PSGL-1 (both are sialomucins and   helix that contains Y686 and S702, which undergoes inducible phos-
               have  analogous  anionic/sulfated  tyrosine  sequences),  the  interaction   phorylation. 1152,1157  Upon phosphorylation, the ITIMs recruit and acti-
               between GPIb and P-selectin appears to be more like the interaction   vate phosphatases, such as SHP-2 and to a lesser extent SHP-1, SHIP,
               between P-selectin and heparin. 1035,1093  In inflamed mesenteric venules   and PP2A, 1158  via their SH2 domains. 1152  PECAM-1 undergoes homo-
               in animals, platelets are observed to roll on the activated endothe-  typic interactions that lead to signaling and crosslinking. 1159  PECAM-1
               lium 1137  and so it is possible that platelet GPIb interacts with endothelial   activation overall thus induces inhibitory activity as the phosphatases
               P-selectin in this interaction. 1093  PSGL-1, a well-documented ligand for   counteract the effects of stimulating kinases, but are complex and ago-
               P-selectin on leukocytes, has also been identified on the surface of plate-  nist specific. PECAM-1 activation decreases platelet responses to ADP
               lets, 1138  and so may also contribute to this interaction.  and  thrombin  and PECAM-1  platelet  expression correlates  inversely
                   GPIbα also binds to high molecular weight kininogen and factor   with platelet sensitivity to these agonists. 1160  PECAM-1 also nega-
               XII, and both of these interactions interfere with thrombin-induced   tively regulates collagen-induced platelet activation mediated by the
               platelet activation. 1139,1140  Factor XI also binds to GPIbα, where it under-  ITAM-bearing GPVI/FcRγ-chain complex, GPIb/IX/V signaling, and
               goes activation by thrombin. 1141  Activated leukocyte integrin  α β ,   laminin-induced activation. 1159  Platelets from mice lacking PECAM-1
                                                                M 2
               also can bind to GPIbα via the I-domain of the integrin, 1142  and this   are hyperresponsive to subthreshold doses of collagen, and when com-
               interaction has been proposed to play an important role in transmigra-  pared to wild-type mice, form larger platelet thrombi on VWF and in
               tion of leukocytes through platelet thrombi at sites of vascular injury.   experimental settings in vivo.
               GPIb plays complex roles in inflammation and endotoxemia in murine   Crosslinking PECAM-1 molecules on the platelet surface with anti-
               models,  demonstrating  both  proinflammatory and  antiinflammatory   bodies enhances platelet adhesion and aggregate formation, suggesting








          Kaushansky_chapter 112_p1829-1914.indd   1868                                                                 17/09/15   3:29 pm
   1888   1889   1890   1891   1892   1893   1894   1895   1896   1897   1898